REPRINT: Though M&A Deals in H1 '06 Flat with Last Year, Size of Recent Pacts Could Trigger More Activity | GenomeWeb

BioCommerce Week Index companies spent at least $13 billion on 13 M&A deals during the first half of 2006 (see table) — compared with at least $2 billion on 13 deals in last year's first half. But the size and expected upshot of a couple of these transactions on the broader life sciences market are expected to push others to follow suit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.